Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional interferon alfa-2b for pterygium
IRCT20120817010617N5Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in pterygium comparing Interferon alfa-2b with Placebo saline (2 arms). Primary endpoints: Pterygium size, Photophobia and 1 more. Started Jan 2020; status: completed.
02
Drugs
interferon alfa-2b
03
Conditions
pterygium
Beyond the preview
Go deeper on IRCT20120817010617N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120817010617N5.